Creative Medical Technology Holdings, Inc.

CELZ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $7.2M $5.9M $3.5M $8.3M $10.7M $98.0K $88.6K $304.1K
Accounts Receivable $0 $2.5K $0 $5.6K $9.6K
Inventory $0 $2.2K $6.6K $10.2K $10.9K $0
Total Current Assets $7.4M $6.1M $10.3M $18.7M $10.7M $98.0K $94.2K $313.7K
Property, Plant & Equipment
Goodwill
Intangible Assets (Excl. Goodwill) $407.2K $530.6K $441.0K $435.6K $527.7K $619.8K $436.6K $163.5K
Total Assets $7.8M $6.7M $10.7M $19.2M $11.3M $717.8K $530.8K $477.2K
Liabilities
Accounts Payable $270.7K $273.5K $317.3K $3.3M $761.9K $350.9K $320.8K $331.8K
Total Current Liabilities $284.9K $327.6K $371.4K $3.3M $1.1M $40.5M $8.6M $4.5M
Long-Term Debt
Total Liabilities $284.9K $327.6K $371.4K $3.3M $1.1M $40.5M $8.6M $4.5M
Stockholders' Equity
Retained Earnings $-70.6M $-64.6M $-59.1M $-53.8M $-43.7M $-61.9M $-25.6M $-17.1M
Total Stockholders' Equity $7.5M $6.3M $10.3M $15.9M $10.2M $-39.8M $-8.1M $-4.0M
← Newer Page 1 of 3 Older →